Analysis of circulating tumor DNA from atebimetinib-treated patients shows acquired MAPK pathway alterations are rare, supporting observed ...
Figure 1: Key signaling pathways and targeted factors in dysregulated BC. This figure illustrates the major signaling pathways and their intricate crosstalk in BC, focusing on the GPCR, RTKs, ...
A multicenter, open-label, phase I/II study of FN-1501 in patients with advanced solid tumors and acute myeloid leukemia. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This ...
Ras dimerization is critical for Raf activation. Here we show that the Ras binding domain of Raf (Raf-RBD) induces robust Ras dimerization at low surface densities on supported lipid bilayers and, to ...
Neoadjuvant Immunotherapy: Leveraging the Immune System to Treat Early-Stage Disease Targeted inhibition using small molecule inhibitors works in smoking-related lung cancer. Responses with ...
SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for ...
For the purpose of clarity, the signaling pathways can be discussed in isolation. However, in reality there is considerable cross-talk between pathways, with parallel or upstream input from other ...
Revolution Medicines shared Phase III clinical trial results for a pill called daraxonrasib in patients with previously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results